Safety Shot Announces First Peer-Reviewed Publication of Human Clinical Trial Confirming Rapid Alcohol Reduction and Hangover Prevention
Portfolio Pulse from
Safety Shot, Inc. has announced the publication of a peer-reviewed study in the Journal of Nutrition and Dietary Supplements. The study confirms the efficacy of Safety Shot® in reducing ethanol levels and preventing hangovers, following a randomized, double-blind, placebo-controlled clinical trial.
March 04, 2025 | 1:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Safety Shot, Inc. has published a peer-reviewed study confirming the effectiveness of its product in reducing alcohol levels and preventing hangovers. This could positively impact the company's stock price.
The publication of a peer-reviewed study confirming the efficacy of Safety Shot® is likely to boost investor confidence and potentially increase demand for the product, positively impacting the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100